Cytek Biosciences Cash Flow Statement 2020-2025 | CTKB

Fifteen years of historical annual cash flow statements for Cytek Biosciences (CTKB).

Annual Data | Millions of US $ except per share data

Metric Name
Net Income/Loss
Total Depreciation And Amortization - Cash Flow
Other Non-Cash Items
Total Non-Cash Items
Change In Accounts Receivable
Change In Inventories
Change In Accounts Payable
Change In Assets/Liabilities
Total Change In Assets/Liabilities
Cash Flow From Operating Activities
Net Change In Property, Plant, And Equipment
Net Change In Intangible Assets
Net Acquisitions/Divestitures
Net Change In Short-term Investments
Net Change In Long-Term Investments
Net Change In Investments - Total
Investing Activities - Other
Cash Flow From Investing Activities
Net Long-Term Debt
Net Current Debt
Debt Issuance/Retirement Net - Total
Net Common Equity Issued/Repurchased
Net Total Equity Issued/Repurchased
Total Common And Preferred Stock Dividends Paid
Financial Activities - Other
Cash Flow From Financial Activities
Net Cash Flow
Stock-Based Compensation
Common Stock Dividends Paid
20242023202220212020
$-6.02$-12.15$2.48$3.03$19.41
$10.49$9.23$5.66$1.24$0.60
$13.20$18.71$19.55$9.01$2.68
$23.69$27.94$25.21$10.25$3.28
$-5.43$-7.33$-19.74$-12.37$0.33
$14.76$4.29$-17.65$-7.07$-5.70
$2.58$-1.78$1.86$-0.26$-0.06
$-3.38$-6.41$-11.86$0.07$-5.38
$7.71$-10.51$-39.93$-8.65$-7.54
$25.38$5.28$-12.23$4.63$15.16
$-3.24$-4.65$-9.75$-4.36$-1.55
$-0.20$-0.18$-0.12$0$0
$-0.47$-44.90$0$-17.00$0
$-79.06$-43.94$-44.45$0.00$0
$0$-0.24$-1.59$0.37$0
$-79.06$-44.17$-46.04$0.37$0
$0$0$0$0$0
$-82.97$-93.89$-55.91$-20.99$-1.55
$-0.56$-0.57$2.93$-2.77$2.77
$4.18$0$0$0$0
$3.62$-0.57$2.93$-2.77$2.77
$-18.89$-40.83$2.79$216$0.17
$-18.89$-40.83$2.79$216$120
$0$0$0$0$0
$-0.55$-0.42$-0.21$0$0
$-15.82$-41.81$5.51$214$123
$-68.89$-131.87$-65.12$198$136
$26.85$22.05$16.60$6.59$0.61
$0$0$0$0$0